COVID-19

News

Sanofi/GSK restart COVID-19 vaccine trials after tweaking fo...

Sanofi and GlaxoSmithKline are restarting clinical development of their COVID-19 vaccine, which was delayed after hitting a snag late last year.

News

Novavax provides 1.1 billion COVID shots to global vaccine d...

Novavax has signed a deal to provide 1.1 billion doses of its COVID-19 vaccine to the COVAX global initiative led by Gavi, the vaccine alliance, which aims to ensure fair access across the

News

Scientists make case for one dose of Pfizer’s COVID jab to s...

Two researchers have suggested that the second dose of Pfizer and BioNTech’s COVID-19 vaccine could be delayed, as this would increase the number of people that can be protected while suppl

News

UK will start first COVID-19 challenge study “within a month...

Sometime within the next few weeks, young and healthy volunteers will be deliberately exposed to the COVID-19 coronavirus in the UK in what looks set to be the first study of its type world

News

Livi fights anti-vaxxers with digital patient messaging camp...

Digital health firm Livi is planning to step up its digital campaign to encourage people to get their COVID-19 vaccines in the UK, with messaging designed to provide accurate information to

Views & Analysis

No cooling off for pharma digital transformation in 2021

COVID-19 has already proved to be a digital accelerant for the pharmaceutical industry, sparking new ideas into life and lighting a fire underneath existing plans that had, in retrospect, y

Sanofi/GSK restart COVID-19 vaccine trials after tweaking fo...

Novavax provides 1.1 billion COVID shots to global vaccine d...

Scientists make case for one dose of Pfizer’s COVID jab to s...

UK will start first COVID-19 challenge study “within a month...

Livi fights anti-vaxxers with digital patient messaging camp...

No cooling off for pharma digital transformation in 2021

Obesity-focused biotech Kailera joins IPO queue in US

Using AI-driven synthetic personas to take your insights fur...

COVID-19

Editor's Picks